217 related articles for article (PubMed ID: 8915309)
21. Late syphilis mimicking a pseudolymphoma of the skin.
Erfurt C; Lueftl M; Simon M; Schuler G; Schultz ES
Eur J Dermatol; 2006; 16(4):431-4. PubMed ID: 16935805
[TBL] [Abstract][Full Text] [Related]
22. Cutaneous drug eruptions: a 5-year experience.
Gerson D; Sriganeshan V; Alexis JB
J Am Acad Dermatol; 2008 Dec; 59(6):995-9. PubMed ID: 19022101
[TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus disease during severe drug eruptions: report of 2 cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome.
Asano Y; Kagawa H; Kano Y; Shiohara T
Arch Dermatol; 2009 Sep; 145(9):1030-6. PubMed ID: 19770444
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathological and genotypic aspects of anticonvulsant-induced pseudolymphoma syndrome.
Choi TS; Doh KS; Kim SH; Jang MS; Suh KS; Kim ST
Br J Dermatol; 2003 Apr; 148(4):730-6. PubMed ID: 12752131
[TBL] [Abstract][Full Text] [Related]
25. Pseudolymphomatous cutaneous angiosarcoma: a rare variant of cutaneous angiosarcoma readily mistaken for cutaneous lymphoma.
Requena L; Santonja C; Stutz N; Kaddu S; Weenig RH; Kutzner H; Menzel T; Cerroni L
Am J Dermatopathol; 2007 Aug; 29(4):342-50. PubMed ID: 17667166
[TBL] [Abstract][Full Text] [Related]
26. Cytomorphologic spectrum of small lymphocytic lymphoma in patients with an accelerated clinical course.
Shin HJ; Caraway NP; Katz RL
Cancer; 2003 Oct; 99(5):293-300. PubMed ID: 14579296
[TBL] [Abstract][Full Text] [Related]
27. Orbital lymphoproliferative tumors: analysis of clinical features and systemic involvement in 160 cases.
Demirci H; Shields CL; Karatza EC; Shields JA
Ophthalmology; 2008 Sep; 115(9):1626-31, 1631.e1-3. PubMed ID: 18440641
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous Rosai-Dorfman disease: clinicopathological profiles, spectrum and evolution of 21 lesions in six patients.
Wang KH; Chen WY; Liu HN; Huang CC; Lee WR; Hu CH
Br J Dermatol; 2006 Feb; 154(2):277-86. PubMed ID: 16433797
[TBL] [Abstract][Full Text] [Related]
29. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
[TBL] [Abstract][Full Text] [Related]
30. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
[TBL] [Abstract][Full Text] [Related]
31. Drug-induced CD30+ T cell pseudolymphoma.
Fukamachi S; Sugita K; Sawada Y; Bito T; Nakamura M; Tokura Y
Eur J Dermatol; 2009; 19(3):292-4. PubMed ID: 19336342
[No Abstract] [Full Text] [Related]
32. Prognostic value of blood eosinophilia in primary cutaneous T-cell lymphomas.
Tancrède-Bohin E; Ionescu MA; de La Salmonière P; Dupuy A; Rivet J; Rybojad M; Dubertret L; Bachelez H; Lebbé C; Morel P
Arch Dermatol; 2004 Sep; 140(9):1057-61. PubMed ID: 15381544
[TBL] [Abstract][Full Text] [Related]
33. Vaccination-induced cutaneous pseudolymphoma.
Maubec E; Pinquier L; Viguier M; Caux F; Amsler E; Aractingi S; Chafi H; Janin A; Cayuela JM; Dubertret L; Authier FJ; Bachelez H
J Am Acad Dermatol; 2005 Apr; 52(4):623-9. PubMed ID: 15793512
[TBL] [Abstract][Full Text] [Related]
34. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes.
Akpek EK; Ahmed I; Hochberg FH; Soheilian M; Dryja TP; Jakobiec FA; Foster CS
Ophthalmology; 1999 Sep; 106(9):1805-10. PubMed ID: 10485554
[TBL] [Abstract][Full Text] [Related]
35. Cutaneous pseudolymphoma associated with bromocriptine therapy.
Wiesli P; Joos L; Galeazzi RL; Dummer R
Clin Endocrinol (Oxf); 2000 Nov; 53(5):656-7. PubMed ID: 11106930
[No Abstract] [Full Text] [Related]
36. Tissue eosinophils and the perils of using skin biopsy specimens to distinguish between drug hypersensitivity and cutaneous graft-versus-host disease.
Marra DE; McKee PH; Nghiem P
J Am Acad Dermatol; 2004 Oct; 51(4):543-6. PubMed ID: 15389188
[TBL] [Abstract][Full Text] [Related]
37. Cutaneous pseudolymphoma: an unusual eyelid presentation.
Cloke A; Lim LT; Crofts KP
Semin Ophthalmol; 2012; 27(1-2):35-6. PubMed ID: 22352826
[TBL] [Abstract][Full Text] [Related]
38. [Pseudolymphoma of the skin: ambiguous terminology: a survey among dermatologists and pathologists].
Levy E; Godet J; Cribier B; Lipsker D
Ann Dermatol Venereol; 2013 Feb; 140(2):105-11. PubMed ID: 23395491
[TBL] [Abstract][Full Text] [Related]
39. [Late-onset vaccination-induced subcutaneous pseudolymphoma].
Croce S; Lhermitte B; Tomasetto C; Guillard O; Bellocq JP; Chenard MP
Ann Pathol; 2008 Apr; 28(2):146-9. PubMed ID: 18675172
[TBL] [Abstract][Full Text] [Related]
40. Phenytoin hypersensitivity reaction.
Stanley J; Fallon-Pellicci V
Arch Dermatol; 1978 Sep; 114(9):1350-3. PubMed ID: 150818
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
